Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant (HCT)
Condition(s):Acute GVHDLast Updated:November 27, 2020Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Acute GVHDLast Updated:November 27, 2020Not yet recruiting
Condition(s):Autoimmune Hemolytic Anemia; Pure Red Cell Aplasia; Evans SyndromeLast Updated:December 3, 2019Recruiting
Condition(s):Transplant;Failure,KidneyLast Updated:March 31, 2020Recruiting
Condition(s):Heart Transplant Failure and RejectionLast Updated:November 3, 2020Recruiting
Condition(s):KIDNEY TRANSPLANTATIONLast Updated:January 8, 2021Completed
Condition(s):HemochromatosisLast Updated:September 4, 2018Completed
Condition(s):Pure Red Cell AplasiaLast Updated:May 30, 2018Unknown status
Condition(s):Kidney Transplantation; Pancreas Transplantation; DiabetesLast Updated:September 29, 2020Recruiting
Condition(s):Dry Eye; Sjogren SyndromeLast Updated:May 22, 2019Completed
Condition(s):Nephrotic Syndrome; Tacrolimus; PharmacokineticsLast Updated:August 5, 2019Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.